Results 191 to 200 of about 97,810 (274)

Role of Topical Ketoconazole in Therapeutic Hair Care Beyond Seborrhoeic Dermatitis and Dandruff

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Ketoconazole shampoo has well‐documented consistent efficacy and safety in treating dandruff and seborrhoeic dermatitis (SD) when compared to other active antidandruff ingredients such as selenium sulphide, corticosteroids and zinc pyrithione.
Aditya K. Gupta   +2 more
wiley   +1 more source

Impact of Clostridioides difficile Infection on Clinical Outcomes in Hospitalized IBD Patients and the Role of Fecal Microbiota Transplantation: A Retrospective Cohort Study

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Clostridioides difficile infection (CDI) worsens the prognosis of patients with inflammatory bowel disease (IBD). This retrospective cohort study aimed to evaluate the risk factors, clinical manifestations, and outcomes of CDI in hospitalized patients with IBD, including those with toxin A/B results between April 2007 and April 2021.
Puo‐Hsien Le   +10 more
wiley   +1 more source

Secukinumab in refractory non-infectious anterior uveitis. [PDF]

open access: yesFront Ophthalmol (Lausanne)
Olivas-Vergara OM   +5 more
europepmc   +1 more source

Low‐Strip Dorsal Preservation Rhinoplasty Opens the Internal Nasal Valve in Tension Nose Deformity

open access: yesThe Laryngoscope, EarlyView.
The goal of this study was to evaluate the effect of dorsal preservation on internal nasal valve dimensions in noses with an overprojected cartilaginous septum. Ten postmortem human specimen heads with a tension nose deformity were imaged using ultra‐high‐resolution photon‐counting detector computed tomography, before and after low‐strip let down.
Floris V.W.J. van Zijl   +6 more
wiley   +1 more source

Non-adherence to urate lowering therapy in gout after 5 years is related to poor outcomes: results from the NOR-Gout study. [PDF]

open access: yesRheumatology (Oxford)
Uhlig T   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy